))
Insilico Medicine: A Leader in AI-driven Pharma Innovation
Manage episode 412205627 series 3554501
Content provided by Teymour Boutros-Ghali and Felicia Hsu, Teymour Boutros-Ghali, and Felicia Hsu. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Teymour Boutros-Ghali and Felicia Hsu, Teymour Boutros-Ghali, and Felicia Hsu or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Insilico Medicine uses generative AI for drug discovery and has set the trend for AI in the pharmaceutical industry. They have developed an AI platform to identify novel targets and molecules, significantly reducing the time and cost of the drug discovery process. The company has a pipeline of novel molecules and drugs, with one asset in clinical trials for idiopathic pulmonary fibrosis (IPF). They’ve gained the trust of the pharma industry and have partnerships with big pharma and contract research organizations.
Story Notes:
- Introduction and Background of Insilico Medicine
- Understanding Generative AI
- Insilico Medicine's Approach to Drug Discovery
- The Visionary Leadership of Alex Zhavoronkov
To learn more, visit:
https://boldcapitalpartners.com/
5 episodes
Share
